Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan
INCHEON, KOREA–(Business Wire / Korea Newswire)–Samsung Bioepis Co., Ltd. today announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes ‘NIPRO’, a biosimilar referencing Stelara[1] (ustekinumab), developed by Samsung […]